Hasil Pencarian  ::  Simpan CSV :: Kembali

"Cancer patients are at risk for having drug-related problems (DRPs) as they received concentrated electrolyte. This research aims to acquire characteristic descriptions also identify DRPs and their causes among hospitalized cancer patients receiving concentrated electrolyte in Dharmais Cancer Hospital. This is a descriptive research with cross-sectional design study. Data was collected retrospectively based on patients' prescriptions and laboratory results from January to March 2020 obtained from SIMRS. The DRPs were identified via Pharmaceutical Care Network Europe (PCNE) V6.2 and Lexicomp® was used to assess the drug-drug interactions. The data obtained were 159 study samples. The results illustrate that the sample characteristic consisted of 52.83% women and 47.17% men. The age of the patients consisted of 6.29% 19-29 years old, 10.69% 30-39 years old, 18.87% 40-49 years old, 33.96% 50-59 years old and 30.19 % 60 years old and above. The diagnosis of cancer was 98.74% classified as malignant cancer and 1.26% benign cancer. The condition of electrolyte disorder in hospitalized cancer patients consisted of 47.17% hyponatremia, 28.3% hypokalemia, and 24.53% metabolic acidosis. The results of DRPs identification showed that 75 patients (47.17%) had DRPs and 84 patients (52.83%) did not have DRPs. Types of DRPs that occurred was the Adverse Drug Reaction (64.97%) and the Drug Effectiveness (35.03%). Causes of DRPs was consisted of Drug Selection (84.08%) and Dose Selection (15.92%). Therefore, hospitalized cancer patients receiving concentrated electrolyte are susceptible to DRPs, so the review of prescription and therapy drug monitoring needs to be done carefully to reach the target therapy and improve patient safety.Pasien kanker berisiko mengalami masalah terkait obat (MTO) saat menggunakan elektrolit konsentrat. Penelitian ini bertujuan untuk memperoleh gambaran karakteristik dan mengidentifikasi jenis dan penyebab MTO pada pasien kanker rawat inap yang mendapat elektrolit pekat di Rumah Sakit Kanker Dharmais. Penelitian ini merupakan penelitian deskriptif dengan desain penelitian cross sectional. Pengumpulan data dilakukan secara retrospektif berdasarkan resep pasien dan hasil laboratorium periode Januari-Maret 2020 yang diperoleh dari SIMRS. Identifikasi MTO menggunakan klasifikasi Pharmaceutical Care Network Europe (PCNE) versi 6.2 dan Lexicomp® untuk menganalisis potensi interaksi obat-obat. Data yang diperoleh sebanyak 159 sampel penelitian. Hasil penelitian menunjukkan bahwa karakteristik sampel terdiri dari 54,09% perempuan dan 45,91% laki-laki. Rentang usia pasien terdiri dari 6,29% berusia 19-29 tahun, 10,69% berusia 30-39 tahun, 18,87% berusia 40-49 tahun, 33,96% berusia 50-59 tahun, dan 30,82%. berusia 60 tahun ke atas. 98,74% dari diagnosis kanker diklasifikasikan sebagai kanker ganas dan 1,26% adalah kanker jinak. Kondisi gangguan keseimbangan elektrolit pada pasien kanker rawat inap adalah hiponatremia 47,17%, hipokalemia 28,3%, dan asidosis metabolik 24,53%. Hasil identifikasi MTO menunjukkan sebanyak 75 pasien (47,17%) mengalami MTO dan 84 pasien (52,83%) tidak mengalami MTO. Jenis MTO yang terjadi adalah Reaksi Obat Tidak Diinginkan (ROTD) (64,97%) dan Masalah Efektivitas Terapi (35,03%). Penyebab MTO terdiri dari pemilihan obat (84.08%) dan pemilihan dosis (15.92%). Oleh karena itu, pasien kanker rawat inap yang mendapat elektrolit pekat cenderung mengalami MTO, sehingga penilaian resep dan pemantauan terapi obat perlu dilakukan secara cermat untuk mencapai target terapeutik dan meningkatkan keselamatan pasien."

"Kemoterapi merupakan salah satu modalitas terapi kanker payudara. Kombinasi dari 5-fluorourasil, doksorubisin, dan siklofosfamid (FAC) adalah protokol kemoterapi yang paling banyak digunakan. Penelitian ini bertujuan untuk mengidentifikasi masalah terkait obat pada pasien kanker payudara yang menjalani kemoterapi FAC di Rumah Sakit Kanker Dharmais dalam periode Juli-Desember 2019. Penelitian dilakukan menggunakan metode observasional deskriptif dengan desain penelitian potong lintang (cross-sectional) menggunakan data restropektif. Masalah terkait obat yang diidentifikasi pada penelitian ini, meliputi dosis dan interaksi obat. Hasil penelitian menunjukkan insiden kanker payudara tertinggi pada kelompok umur 44-54 tahun (43,70%) dan penggunaan obat penunjang tertinggi terdapat pada ondansetron (27,17%). Masalah terkait obat dengan dosis yang tidak sesuai sebesar 9,24%, di mana 7,56% dosis terlalu rendah dan 1,68% dosis terlalu tinggi, dan interaksi obat sebesar 9,24%, dimana 25% kategori mayor, 69,44% kategori moderat, dan 5,56% kategori minor. Penatatalaksana kemoterapi FAC pada pasien kanker payudara berpotensi menyebabkan masalah terkaitobat. Oleh karena itu, perlu pemantauan terapi obat pada pasien agar masalah terkait obat dapat diminimalisasi sehingga keberhasilan terapi dapat tercapai.

---

Chemotherapy is one of the modalities of breast cancer therapy. The combination of 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) is the most widely use chemotherapy protocol. This study aims to identify drug-related problems in breast cancer patients undergoing FAC chemotherapy at Dharmais Cancer Hospital in the period July-December 2019. The study was conducted using descriptive observational methods with cross-sectional research designs using restropective data. Drug-related problems identified in this study included dosage and drug interactions.

The results showed the highest breast cancer incident showed in the age group 44-54 years old (43.70%) and the highest use of supportive therapy was found in ondansetron (27.17%). Percentage of inappropriate doses was 9.24% with 7.56% doses too low and 1.68% doses too high, and drug interactions by 9.24%, where 25% the major category, 69.44% the moderate category, and 5.56% the minor category. Management of FAC chemotherapy in breast cancer patients has the potential to cause drug-related problems. Therefore, it is necessary to monitor drug therapy in patients so that drug-related problems can be minimized andtherapeutic success can be achieved."

"Terapi Paliatif bertujuan untuk meningkatkan kualitas hidup dan mengurangi gejala, namun menambah kompleksitas terapi pasien. Penelitian ini bertujuan untuk menganalisis profil pengobatan dan prevalensi DRPs yang terjadi pada pasien yang menjalani terapi paliatif di RSK 'Dharmais'. Penelitian ini adalah penelitian cross sectional. Data pada penelitian diambil secara prospektif dari data medis pasien bulan maret sampai juni 2011. Karakteristik pasien, 33 orang (68,8%) perempuan, 15 orang (31,3%) laki-laki, dan kasus kanker padat terbesar adalah kasus kanker payudara sebanyak 15 orang (33,3%). Berdasarkan profil pengobatan, 64,6% hanya menjalani satu kali terapi paliatif. Reaksi obat yang tidak diinginkan (ROTD) manifestasi dialami olah 70,1% subyek uji dan 66,2% mengalami ROTD potensial. Lima koma tujuh persen (5,7%) mengalami interaksi dengan signifikansi moderate dan 15,0% terjadi karena pemakaian morphine, dan amitriptyline. Peningkatan risiko kejadian ROTD dipengaruhi oleh (1) usia, bertambahnya usia tidak selalu menyebabkan peningkatan ROTD manifestasi; (2) jenis kelamin, laki-laki akan lebih berisiko mengalami peningkatan ROTD manifestasi; (3) riwayat rejimen kemoterapi kuratif, meningkatkan risiko ROTD manifestasi; (4) penyakit penyerta, meningkatkan risiko ROTD manifestasi dan potensial; (5) jumlah obat; penggunaan > 5 jenis obat dapat meningkatkan risiko ROTD manifestasi dan ROTD potensial. Risiko kejadian interaksi obat dipengaruhi oleh faktor adanya penyakit penyerta dan penggunaan > 5 jenis obat.

---

The goal of palliative care is to increase the quality of life and to reduce the symptomps, but its often increace the complexity of patient's therapy. The aim of these research is to analyst the patient's therapy profile and the prevalence of DRPs of patient undergoing the palliative care at 'Dharmais' Hospital National Cancer Center. This reasearch is a cross sectional study. The data of the research is prospectively taken from the patients' medical records start from march to june 2011. The patient characteristic who followed the reasearch are 33 patients (68.8%) women, 15 patient (31.3%) men, and the most solid cancer case are breast cancer, 15 patients (31.3%). Based on therapy profile, 64.6% only had once palliative care. Manifest adverse reaction happen in 70.1% patient of subject and 66.2% subjects get potential adverse reaction. Five point seven percent (5.7%) of drug interaction had moderate signification, 15.0% caused by the morphine, and amitriptyline use. The risk of incident adverse reactions influenced by (1) age, increasing the age not always increase the risk of having the manifest adverse reaction, (2) sex, men will have higher risk of manifest adverse reaction, (3) history of curative chemotherapy regimen, increase the risk of manifest adverse reaction, (4) comorbidities will increase the risk of manifest and potential adverse reaction, (5) the number of drug use, using more than 5 drugs ( > 5 drugs) will increase the risk of manifest and potential adverse reaction. The risk of drug interaction will increase because of the comorbidities and the number of drugs using ( > 5 drugs)."

"Doksorubisin merupakan salah satu terapi antikanker yang termasuk golongan antrasiklin, memiliki aktivitas klinis pada penyakit kanker payudara. Doksorubisin dapat menimbulkan efek kardiotoksik akibat pembentukan doksorubisinol selaku metabolit utamanya. Salah satu metode biosampling terbaru yaitu volumetric absorptive microsampling memiliki berbagai kelebihan yaitu pengambilan darah secara finger prick, tidak dipengaruhi oleh hematokrit, dan dapat disimpan dalam suhu ruang. Penelitian ini bertujuan untuk menganalisis doksorubisin dan mengetahui reaksi obat merugikan kemoterapi berbasis doksorubisin. Nilai multiple reaction monitoring (MRM) diatur pada m/z 544,22>396,9 untuk doksorubisin; m/z 546,22>398,9 untuk doksorubisinol; dan m/z 528,5>362,95 untuk daunorubisin. Nilai LLOQ yang diperoleh adalah 8 ng/mL untuk doksorubisin dan 3 ng/mL untuk doksorubisinol dengan linearitas 0,9904 untuk doksorubisin dan 0,9902 untuk doksorubisinol. Hasil analisis mendapatkan rentang kadar terukur untuk doksorubisin sebesar 9,47 – 87,84 ng/mL serta rentang kadar terukur untuk doksorubisinol sebesar 4,24 – 54,02 ng/mL. Dosis kumulatif doksorubisin pada pasien sebesar 47,93 – 346,09 mg/m2, hal ini menunjukkan bahwa risiko seluruh pasien terkena kardiomiopati di bawah angka kejadian 4%. Pasien yang mengalami penurunan fraksi ejeksi ventrikel kiri setelah kemoterapi doksorubisin terdiri dari penurunan fraksi ejeksi <10% dan ada 3 pasien yang mengalami penurunan fraksi ejeksi ventrikel kiri >10%. Alopesia merupakan reaksi obat merugikan subjektif yang paling banyak dirasakan pasien diikuti dengan mual dan muntah. Hasil uji hubungan menunjukkan adanya tidak signifikan antara kadar doksorubisin dan doksorubisinol terhadap reaksi obat merugikan pada pasien kanker payudara. Terdapat hubungan signifikan pada kadar doksorubisin terhadap dosis kumulatif dan waktu pengambilan sampel pasien.

---

Doxorubicin is an anticancer therapy belonging to the anthracycline class, which has clinical activity in breast cancer. Doxorubicin can cause cardiotoxic effects due to the formation of doxorubicinol as its main metabolite. One of the newest biosampling methods, namely Volumetric Absorptive microsampling, has many advantages, namely blood collection by finger prick, not affected by hematocrit, and can be stored at room temperature. This study aims to analyze doxorubicin and determine the adverse drug reactions of doxorubicin-based chemotherapy. The multiple reaction monitoring (MRM) value is set at m/z 544.22> 396.9 for doxorubicin; m/z 546.22>398.9 for doxorubicinol; and m/z 528.5>362.95 for daunorubicin. The LLOQ values ​​obtained were 8 ng/mL for doxorubicin and 3 ng/mL for doxorubicinol with a linearity of 0.9904 for doxorubicin and 0.9902 for doxorubicinol. The results of the analysis showed that the measured concentration range for doxorubicin was 9.47 – 87.84 ng/mL and the measured concentration range for doxorubicin was 4.24 – 54.02 ng/mL. The cumulative dose of doxorubicin in patients was 47.93 – 346.09 mg/m2, this shows that the risk of all patient developing cardiomyopathy is below the incidence rate of 4%. Patients who experienced a decrease in left ventricular ejection fraction after doxorubicin chemotherapy consisted of a decrease in ejection fraction <10% and there were 3 patients who experienced a decrease in left ventricular ejection fraction >10%. Alopecia is the most common subjective adverse drug reaction experienced by patients, followed by nausea and vomiting. The results of the relationship test showed that there was no significant relationship between doxorubicin and doxorubicinol levels on adverse drug reactions in breast cancer patients. There is a significant relationship between doxorubicin levels and cumulative dose and patient sampling time.xv,"

"Doksorubisin masih banyak digunakan di Rumah Sakit Kanker Dharmais. Efek samping doksorubisin terhadap jantung yang dapat ditandai dengan adanya penurunan fraksi ejeksi ventrikel kiri perlu mendapatkan perhatian khusus. Penelitian ini bertujuan untuk memperoleh faktor-faktor risiko yang mempengaruhi penurunan fraksi ejeksi ventrikel kiri pada pasien kanker yang mendapatkan kemoterapi doksorubisin di Rumah Sakit Kanker Dharmais. Penelitian dilakukan menggunakan rancangan cross sectional. Data diperoleh dari rekam medis pasien. Populasi adalah pasien kanker yang mendapatkan kemoterapi doksorubisin periode Oktober 2011-Oktober 2013 di Rumah Sakit Kanker Dharmais. Sampel yang memenuhi kriteria inklusi dan ekslusi sebanyak 77 pasien. Faktor-faktor risiko yang dievaluasi adalah jenis kelamin, usia, kombinasi kemoterapi, hipertensi, diabetes mellitus, riwayat penyakit jantung, radiasi pada dada kiri dan penggunaan obat kardiotoksik lain. Penurunan fraksi ejeksi ventrikel kiri setelah kemoterapi doksorubisin terjadi pada 84,5% pasien: penurunan fraksi ejeksi <10% pada 48,1% pasien dan penurunan fraksi ejeksi ventrikel kiri ≥10% pada 36,4% pasien. Hipertensi berpengaruh terhadap penurunan fraksi ejeksi ventrikel kiri ≥10% secara bermakna (p=0,032). Jenis kelamin laki-laki dan radiasi pada dada kiri menunjukkan adanya kecenderungan berhubungan dengan penurunan fraksi ejeksi ventrikel kiri ≥10% (p=0,095 dan p=0,051). Penderita hipertensi yang mendapatkan doksorubisin berpotensi mengalami penurunan fraksi ejeksi ventrikel kiri.

---

Doxorubicin was still widely used in Dharmais Cancer Hospitals. The side effect of doxorubicin to the heart which can be characterized by a decline of left ventricular ejection fraction (LVEF) should received special attention. The aim of this study was to determine risk factors associated with the incidence of LVEF decline in cancer patients treated with doxorubicin at Dharmais Cancer Hospital. The study design was cross sectional. Data was collected from patient?s medical record. The populations were cancer patients who got doxorubicin on October 2011-October 2013 at Dharmais Cancer Hospital. The Samples which fulfilled the inclusion and exclusion criteria were 77 patients. Gender, age, chemotherapy combination, hypertension, diabetes mellitus, cardiac diseases history, left chest wall irradiation and the used of other drugs-induced cardiotoxicity were evaluated as risk factors. The amount of patient that declined their LVEF after doxorubicin chemotherapy was 84.5%, consist of 48.1% patients have ejection fraction fall <10%, and 36.4% patients have ejection fraction fall ≥10%. Hypertension significantly related with decline of LVEF ≥10% (p=0.032). Male sex and left chest wall irradiation showed a trend decline of LVEF ≥10% (p=0.095 and p=0.051). Patients with hypertension who got doxorubicin potentially had declined LVEF."

"Efek samping dari pemberian kemoterapi maupun beban penyakit kanker sering kali meyebabkan gangguan pada semua system dalam tubuh manusia serta masalah psikologis yang akhirnya dapat menyebabkan terjadinya fatigue pada pasien kanker. Tujuan dari penelitian ini adalah untuk mengidentifikasi faktor prediktor yang dapat menyebabkan fatigue. Metode dalam penelitian ini menggunakan analisis korelasi dengan cross sectional, dengan jumlah sampel sebanyak 95. Metode pengambilan sampel dengan menggunakan teknik concecituve samping. Penelitian ini menunjukkan bahwa 72,6% responden adalah perempuan dengan rerata usia 45,54 tahun, rerata kadar Hb 10,881 gr/dl, 38,9% kasus Ca Mammae, 69,5% termasuk stadium lanjut, 30,5% mendapat kemoterapi FAC, 29,5% menjalani kemoterapi lebih dari siklus 4, 55,8% fatigue ringan, 55,8% kategori nyeri sedang-berat, 82,1% kualitas tidur buruk, dan 38,9% termasuk katagori aktif minimal. Hasil penelitian ini menunjukkan bahwa terdapat hubungan yang signifikan (p value 0,05) antara kadar Hb, mual muntah, nyeri, tingkat aktivitas, depresi, dan kualitas tidur dengan fatigue. Analisis berikutnya didapatkan hasil bahwa variabel nyeri merupakan variabel yang berisiko paling besar untuk terjadinya fatigue. Rekomendasi dari penelitian ini adalah pentingnya mengidentifikasi faktor-faktor yang dapat menyebabkan fatigue pada pasien kanker yang menjalan kemoterapi untuk mengurangi risiko kejadian atau semakin parahnya fatigue.

---

Side effect of chemotherapy and burden of cancer often cause interference with all the human body systems as well as psycological problems wich eventually can lead to fatigue in cancer patients. The purpose of the study was to identify predictor faktors that can be cause of fatigue. The method of the research applied correlation analysis with cross sectional. There were 95 respondents. Sample was taken by consecutive sampling technique. The research showed that 72,6% female respondents with 45,54 years of age in average, Hb rate 10,881 gr/dl in average, 38,9% Mammae cancer, 69,5% advanced stage, 30,5 % FAC chemotherapy, 29,5% more than 4 cycles of chemotherapy, 55,8% light fatigue, 55,8% moderate-severe pain, 82,1% bad sleep quality, 38,9% moderate nausea and fomiting, 36,8% bordeline anxiety, 62,1% no depression, and 44,2% minimal active.

The analysis showed that there was a significant relation between Hb, depression, physical activity, sleep quality, pain, nausea and vomiting with fatigue lavel of (p< 0,05). Further analysis showed that pain was the greatest risk for the occurence of fatigue. The reseacher recommends that should be to indentifying another factors that can cause fatigue in cancer patient undergoing chemotherapy to reduce risk occurrence and severity of fatigue."

"Radioterapi merupakan salah satu metode pengobatan utama kanker. Pasien yang akan menjalani radioterapi sangat rentan terhadap kecemasan. Ketidaktahuan mengenai prosedur radioterapi serta efek samping dari radioterapi dapat menimbulkan kecemasan pada pasien yang mendapatkan radioterapi. Tujuan penelitian ini adalah untuk mengetahui faktor-faktor internal yang berhubungan dengan kecemasan pada pasien kanker yang mendapatkan radioterapi di RS Kanker Dharmais tahun 2013. Penelitian ini menggunakan metode deskriptif dengan pendekatan metode Cross Sectional, jumlah sampel 97 responden. Instrument yang digunakan adalah Depression Anxiety Stress Scale (DASS). Berdasarkan hasil penelitian didapatkan pasien dengan tingkat kecemasan ringan (64,9%), kecemasan sedang (18,6%) dan tingkat kecemasan berat (16,5%). Terdapat hubungan antara jenis kelamin, program dan frekuensi radioterapi dengan tingkat kecemasan pasien dibuktikan (p < α : 0,05). Penelitian ini merekomendasikan untuk meningkatkan mutu pelayanan asuhan keperawatan dalam memberikan palayanan berupa konseling dan pendidikan kesehatan diperlukan pada pasien yang mendapatkan radioterapi.

---

Radiotherapy is one of the main methods for cancer treatment. Patients undergoing radiotherapy is very prone to anxiety. Ignorance about the procedure, side effects of radiotherapy can cause anxiety. The purpose of this study was to know the internal factors related to patients receiving radiotherapy at Dharmais Cancer Hospital in 2013. This study used a descriptive cross sectional method approach with 97 patients as a sample. Depression Anxiety Stress Scale (DASS) was used as a instrument. The results shows patients with mild anxiety level (64.9%), moderate anxiety (18.6%), and severe anxiety (16.5%). There was significant corelation between sex and the frequency of radiotherapy program with proved patient's anxiety level (p < α : 0,05). The study recommends to improve the quality of nursing care in providing services such as counseling and health education to reduce patient's anxiety level."

"[ABSTRAKKanker merupakan faktor penting dalam beban penyakit global saat ini.Kasus baru setiap tahun terus meningkat. Angka kasus kanker payudara di RumahSakit Kanker Dharmais masih menempati urutan pertama dari jenis kanker lain.Informasi mengenai kualitas hidup perempuan dengan kanker payudara menjadisangat penting mengingat masih tingginya angka kasus kanker payudara sertauntuk memberikan dukungan kepada pasien kanker payudara dalamkeberlangsungan hidup jangka panjang. Kualitas hidup pasien kanker payudaratak luput dari faktor karakteristik individu, faktor karakteristik klinis dan faktorlingkungan sosial. Penelitian ini menggunakan desain case series dengan 90sampel diambil secara consecutive sampling. Hasil penelitian menunjukkanbahwa usia, terapi yang sedang dijalani, paparan informasi serta dukungankeluarga berhubungan dengan kualitas hidup pasien kanker payudara. Saran untukRumah Sakit Kanker Dharmais agar lebih meningkatkan penyebaran informasitentang kanker payudara, bagi masyarakat meningkatkan dukungan keluargaterhadap pasien kanker payudara.

---

ABSTRACTCancer is an important factor in the current global disease burden. New cases eachyear continues to increase. The numbers of breast cancer cases in the DharmaisHospital Cancer still ranks first than other types of cancer. Information on thequality of life of women with breast cancer becomes very important consideringthe high number of cases of breast cancer and to provide support to breast cancerpatients in the long-term survival. The quality of life of breast cancer patientslitely dependent the individual characteristic, clinical characteristics and socialenvironmental factors. This study used a case series design with 90 samplesemployed consecutive sampling. The results showed that age, the therapy beingundertaken, breast cancer exposure information as well as family support relatedto the quality of life of the breast cancer patients. Suggestions one made to theDharmais Cancer Hospital to further improve the dissemination of informationabout breast cancer, in the family to increase family support for breast cancerpatients.;Cancer is an important factor in the current global disease burden. New cases eachyear continues to increase. The numbers of breast cancer cases in the DharmaisHospital Cancer still ranks first than other types of cancer. Information on thequality of life of women with breast cancer becomes very important consideringthe high number of cases of breast cancer and to provide support to breast cancerpatients in the long-term survival. The quality of life of breast cancer patientslitely dependent the individual characteristic, clinical characteristics and socialenvironmental factors. This study used a case series design with 90 samplesemployed consecutive sampling. The results showed that age, the therapy beingundertaken, breast cancer exposure information as well as family support relatedto the quality of life of the breast cancer patients. Suggestions one made to theDharmais Cancer Hospital to further improve the dissemination of informationabout breast cancer, in the family to increase family support for breast cancerpatients.;Cancer is an important factor in the current global disease burden. New cases eachyear continues to increase. The numbers of breast cancer cases in the DharmaisHospital Cancer still ranks first than other types of cancer. Information on thequality of life of women with breast cancer becomes very important consideringthe high number of cases of breast cancer and to provide support to breast cancerpatients in the long-term survival. The quality of life of breast cancer patientslitely dependent the individual characteristic, clinical characteristics and socialenvironmental factors. This study used a case series design with 90 samplesemployed consecutive sampling. The results showed that age, the therapy beingundertaken, breast cancer exposure information as well as family support relatedto the quality of life of the breast cancer patients. Suggestions one made to theDharmais Cancer Hospital to further improve the dissemination of informationabout breast cancer, in the family to increase family support for breast cancerpatients.;Cancer is an important factor in the current global disease burden. New cases eachyear continues to increase. The numbers of breast cancer cases in the DharmaisHospital Cancer still ranks first than other types of cancer. Information on thequality of life of women with breast cancer becomes very important consideringthe high number of cases of breast cancer and to provide support to breast cancerpatients in the long-term survival. The quality of life of breast cancer patientslitely dependent the individual characteristic, clinical characteristics and socialenvironmental factors. This study used a case series design with 90 samplesemployed consecutive sampling. The results showed that age, the therapy beingundertaken, breast cancer exposure information as well as family support relatedto the quality of life of the breast cancer patients. Suggestions one made to theDharmais Cancer Hospital to further improve the dissemination of informationabout breast cancer, in the family to increase family support for breast cancerpatients., Cancer is an important factor in the current global disease burden. New cases eachyear continues to increase. The numbers of breast cancer cases in the DharmaisHospital Cancer still ranks first than other types of cancer. Information on thequality of life of women with breast cancer becomes very important consideringthe high number of cases of breast cancer and to provide support to breast cancerpatients in the long-term survival. The quality of life of breast cancer patientslitely dependent the individual characteristic, clinical characteristics and socialenvironmental factors. This study used a case series design with 90 samplesemployed consecutive sampling. The results showed that age, the therapy beingundertaken, breast cancer exposure information as well as family support relatedto the quality of life of the breast cancer patients. Suggestions one made to theDharmais Cancer Hospital to further improve the dissemination of informationabout breast cancer, in the family to increase family support for breast cancerpatients.]"

"Kanker merupakan penyakit genetik dimana pengaturan sel, karakteristik sel dan fungsi sel normal berubah. Penyakit kanker terus menjadi masalah kesehatan yang signifikan di masyarakat di seluruh dunia dan di Indonesia. Salah satu kanker yang berdampak pada kerusakan sistem neurologis dan menurunkan kualitas hidup adalah meningioma. Praktik asuhan keperawatan pada pasien kanker memerlukan pendekatan teori keperawatan. Karya Ilmiah Akhir merupakan laporan praktik residensi keperawatan medikal bedah peminatan onkologi di rumah sakit kanker Dharmais. Karya ilmiah ini terdiri dari: (1) penerapan theory of comfort, (2) penerapan program orientasi pasien pra kemoterapi sebagai evidence based nursing, serta (3) modified early warning score sebagai proyek inovasi kelompok. Kesimpulan theory of comfort tepat digunakan dalam perawatan pasien kanker. Intervensi pemberian program orientasi pasien pra kemoterapi dan inovasi modified early warning score dapat diaplikasikan dalam perawatan pasien kanker baik dirawat inap maupun rawat jalan.

---

Cancer is a genetic disease in which the composition of cells, cell characteristics and normal cell function has been changed. Cancer continues to be a significant health problem in communities throughout globally and specifically in Indonesia. Type of cancer which affects the damage of neurological system and degrade the quality of life called meningioma. The practice of nursing care in cancer patients requiring nursing theory approach. Scientific final paper is type of report of residency medical-surgical nursing practice specialization in oncology at the Dharmais Cancer Hospital. This scientific work consists of: (1) The application of comfort theory, (2) The application of pre-chemotherapy patient orientation program as evidence based nursing practice, and (3) modified early warning score as an innovation of the group project. It conclude the theory of comfort is appropriate to use in the treatment of cancer patients. The Intervention of prechemotherapy patient orientation program and modified early warning score innovation could be applied in the treatment of care for cancer patients both hospitalized and outpatients."

"Geriatri rentan terhadap masalah terkait obat dikarenakan perubahan fisiologis yang berkaitan dengan usia yang dapat mengubah sifat farmakokinetik dan farmakodinamik obat, komorbiditas dan penggunaan beberapa obat. Penelitian ini bertujuan untuk menganalisis masalah terkait obat pada pasien rawat inap geriatri dengan diabetes mellitus di RSPAD Gatot Soebroto tahun 2015 yang dianalisis berdasarkan PCNE V6.2. Pengambilan data dilakukan secara prospektif menggunakan resep, rekam medis, kardeks/catatan perawat. Sampel penelitian adalah data 26 pasien geriatri dengan DM yang memenuhi kriteria inklusi yaitu yaitu resep, rekam medis, kardeks/catatan perawat yang dapat terbaca dan lengkap, data pasien dengan usia > 60 tahun dan data pasien yang menjalani rawat inap maksimal satu bulan perawatan periode Februari - April tahun 2015. Analisis dilakukan terhadap 299 terapi obat dari 26 pasien. Terdapat 166 jumlah masalah yang berhasil diidentifikasi. Persentase masalah efektivitas terapi (50,6%) dan reaksi obat yang tidak dikehendaki (49,4%) dengan penyebab yang paling besar dikarenakan kombinasi obat-obat atau obat-makanan tidak tepat termasuk kejadian interaksi obat (20,4%).

---

Geriatric is vulnerable to drug-related problems due to physiological changes associated with age which can alter the pharmacokinetic and pharmacodynamic properties of drugs, comorbidities and use of some medications. This study aimed to analyze drug-related problems in hospitalized geriatric patients with diabetes mellitus at Gatot Soebroto Army Center Hospital 2015, drug related problems were analyzed based on PCNE V6.2. Data were collected prospectively using prescriptions, medical records, index card/nurses records. Sample was data of 26 hospitalized geriatric patients which were readable and complete prescriptions, medical records, index card/nurses records, data of patients with age > 60 years and patient data who got inpatient treatment maximum one month from February to April 2015. The analysis was conducted to 299 drug treatment of 26 patients. One hundred and sixty six number of problems were identified. The percentage of treatment effectiveness (50.6%) and adverse drug reactions (49.4%) with the greatest causes due to a combination of drug-drug or drug-food inappropriately including the incidence of drug interactions (20.4%)."